Cover Image

Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches

The aldose reductase (AR) enzyme is an important target enzyme in the development of therapeutics against hyperglycaemia induced health complications such as retinopathy, etc. In the present study, a quantitative structure activity relationship (QSAR) evaluation of a dataset of 226 reported AR inhib...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ravindra L. Bakal (Author), Rahul D. Jawarkar (Author), J.V. Manwar (Author), Minal S. Jaiswal (Author), Arabinda Ghosh (Author), Ajaykumar Gandhi (Author), Magdi E.A. Zaki (Author), Sami Al-Hussain (Author), Abdul Samad (Author), Vijay H. Masand (Author), Nobendu Mukerjee (Author), Syed Nasir Abbas Bukhari (Author), Praveen Sharma (Author), Israa Lewaa (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
by: R. D. Jawarkar, et al.
Published: (2021)

Response of a Human Lens Epithelial Cell Line to Hyperglycemic and Oxidative Stress: The Role of Aldose Reductase
by: Gemma Sardelli, et al.
Published: (2023)

Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis
by: Magdi E. A. Zaki, et al.
Published: (2021)

Aldose reductase, oxidative stress and diabetic mellitus
by: Waiho eTang, et al.
Published: (2012)

The Activity of Aldose Reductase Is Elevated in Diabetic Mouse Heart
by: Kazumi Iwata, et al.
Published: (2007)

Stereoselectivity of Aldose Reductase in the Reduction of Glutathionyl-Hydroxynonanal Adduct
by: Francesco Balestri, et al.
Published: (2019)

Soyasaponins from Zolfino bean as aldose reductase differential inhibitors
by: Francesco Balestri, et al.
Published: (2019)

Exosome‐based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV‐mediated cervical cancer treatment
by: Nobendu Mukerjee, et al.
Published: (2024)

Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
by: Syed Nasir Abbas Bukhari, et al.
Published: (2022)

In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
by: Arumugam Madeswaran, et al.
Published: (2012)

The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017)

Docking studies: In silico aldose reductase inhibitory activity of commercially available flavonoids
by: Muthuswamy Umamaheswari, et al.
Published: (2012)

Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures
by: Magdi E. A. Zaki, et al.
Published: (2022)

Aldose Reductase Inhibitors Improve Myocardial Reperfusion Injury in Mice by a Dual Mechanism
by: Kazumi Iwata, et al.
Published: (2006)

Aldose Reductase Inhibitory Potential and Anti-cataract Activity of Punica granatum Fruit Extract
by: S.N. Mestry, et al.
Published: (2016)

Inhibition behaviours of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study
by: Zuhal Alim, et al.
Published: (2017)

Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway
by: Haifei Xie, et al.
Published: (2022)

Inhibition of Ocular Aldose Reductase by a New Benzofuroxane Derivative Ameliorates Rat Endotoxic Uveitis
by: C. Di Filippo, et al.
Published: (2014)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
by: Robert Ancuceanu, et al.
Published: (2024)

Thymol, a monoterpene, inhibits aldose reductase and high-glucose-induced cataract on isolated goat lens
by: Divya M Kanchan, et al.
Published: (2016)

Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis
by: Magdi E. A. Zaki, et al.
Published: (2022)

Antidiabetic and aldose reductase inhibitory potentials of Land caltrops aqueous extract in streptozotocin-nicotinamide induced diabetic rats
by: Bheemesh Vangalapati, et al.
Published: (2020)

Models of enzyme inhibition and apparent dissociation constants from kinetic analysis to study the differential inhibition of aldose reductase
by: Francesco Balestri, et al.
Published: (2022)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
by: Sangeetha Iyer, et al.
Published: (2019)

PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer
by: Swastika Maitra, et al.
Published: (2024)

Tear exosome‐based PROteolysis TArgeting Chimeras nanomedicine for human immunodeficiency virus‐mediated cancer treatment
by: Nobendu Mukerjee
Published: (2024)

Evaluation of Pharmacokinetic Parameters, Toxicity, and Molecular Docking of Flavonols with Aldose Reductase Enzyme to Find an Effective Compound in Inhibition of this Enzyme
by: Morteza Sadeghi, et al.
Published: (2020)

Transcription Factor Nrf2 Regulates Promoter Activity of Mouse Aldose Reductase (AKR1B3) Gene
by: Toru Nishinaka, et al.
Published: (2005)

Effective fraction of Teucrium polium suppressed polyol pathway through inhibiting the aldose reductase enzyme: strategy to reduce retinopathy
by: Somayeh Amraee, et al.
Published: (2020)

Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity
by: Felicia D'Andrea, et al.
Published: (2020)

α-Amylase, α-glucosidase and aldose reductase inhibitory and molecular docking studies on Tinospora cordifolia (Guduchi) leaf extract
by: Hemlata Janardhan Bhosale, et al.
Published: (2024)

Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats
by: Takafumi Matsumoto, et al.
Published: (2008)

Carica papaya Linn. fruit extract inhibited the activities of aldose reductase and sorbitol dehydrogenase: possible mechanism for amelioration of diabetic complications
by: Mutiu Idowu Kazeem, et al.
Published: (2020)

The prostaglandin F synthase activity of the human aldose reductase AKR1B1 brings new lenses to look at pathologic conditions.
by: Eva eBresson, et al.
Published: (2012)

Detoxifying enzymes at the cross-roads of inflammation, oxidative stress and drug hypersensitivity: role of glutathione transferase P1-1 and aldose reductase
by: Francisco J Sánchez-Gómez, et al.
Published: (2016)

Three-dimensional quantitative structure-activity relationships and docking studies of some structurally diverse flavonoids and design of new aldose reductase inhibitors
by: Utpal Chandra De, et al.
Published: (2015)

Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats
by: Takafumi Matsumoto, et al.
Published: (2008)

Signature of click chemistry in exosome modification for cancer therapeutic
by: Nobendu Mukerjee, et al.
Published: (2024)

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
by: Abdelrahman Hamdi, et al.
Published: (2023)

Novel 2-phenoxypyrido[3,2-b]pyrazin-3(4H)-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity
by: Xin Hao, et al.
Published: (2019)